Table 2 Previous treatments received by patients in the study
Agent Type | Number Treated |
|---|---|
Alkylating Agent | |
Temozolomide | 20 |
Cisplatin | 8 |
Oxaliplatin | 6 |
Topoisomerase Inhibitor | |
Irinotecan | 9 |
Antimetabolite | |
Capecitabine | 24 |
DNA Synthesis Inhibitor | |
Etoposide | 12 |
m-TOR Inhibitor | |
Everolimus | 42 |
Sirolimus | 1 |
VEGF Inhibitor | |
Sunitinib | 6 |
PD-1 Inhibitor | |
Pembrolizumab | 4 |
Nivolumab | 4 |
CTLA-4 Blockade | |
Ipilimumab | 2 |